The global spine biologics market is expected to reach USD 2.7 billion by 2022 at a CAGR of 4.4% from 2016 to 2022.
The Global Spine Biologics market is segmented on the basis of product type, surgery type and geography.
For Sample Report Global Spine Biologics Market– Trends and Forecast to 2024
Biologics assist the natural process of bone formation. They can also be used as products that can cure the diseaseor degenerated discs. Biologics for spine includes all the biological materials that play a role in a spinal procedure;these are one of the most innovative advances in spine surgical treatment. These are implants used in lieuallografts or as a support for bones in and around the spinal region.
To read more about the scope and findings of this report visit Global Spine Biologics Market is poised to grow at 4.3% from 2016 to 2022
On the basis of product type the spine biologics market is segmented into bone grafts; bone graft substitutes; platelet-rich plasma (PRP) and bone marrow aspirate therapy among others.
Based on surgery type, the market is segmented into Anterior Cervical Discectomy and Fusion (ACDF); Transforamenal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF) among others.
On the basis of end-users the market is segmented into Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others.
Based on geography the global spine biologics market report studies major regions, such as North America, Europe, South America, Asia-Pacific, and Rest of the World (RoW). North America contributed the largest share of 69.3% to the global spine biologics market, followed by Europe. The North American spine biologics market has witnessed significant growth in the recent years, as a result of the increased population, rise in awareness of newly developed technologies, increased per capita income, and improved medical literacy and tourism, among others. The increasing ageing population and growing health concerns have led governments across the region to take several initiatives, thereby resulting in growth in the market.
Some of the major players in the spine biologics market report include Arthrex, Inc., Cesca Therapeutics, Inc., DepuySynthes, Inc., DMP Spine, Exactech, Inc., K2m, Inc., Lattice Biologics, Medtronic, Nuo Therapeutics, Inc., Nutech, Nuvasive, Inc., Orthofix Holdings, Inc., Regen Lab Sa, RTI Surgical, Inc., Stryker Corporation, Wright Medical Technology, Inc., X-Spine Systems, Inc., Zimmer Holdings, Inc., and others.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Global Hip Replacement Implants Market, By Product Type (Cemented Total Hip Implant, Cement Free Total Hip Implant, Partial Femoral Head Implant, Hip Resurfacing, Revision Hip Implants), By End-Users (Orthopedic Clinics, Hospitals, Surgery Centers), By Surgery Numbers (Total Hip Replacement, Partial Hip Replacement, Revision Hip Replacement, Hip Resurfacing), By Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) – Industry Trends and Forecast to 2024
Company Name: Data Bridge Market Research Private Limited
Contact Person: Ravi Dubey
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar